Primary immune thrombocytopenia has the potential to worsen as the disease causes internal bleeding due to thrombocytopenia. Primary immune thrombocytopenia is a relatively common bleeding disorder, mainly due to the abnormal functioning of the immune system, which attacks its own platelets leading to their massive destruction. When the number of platelets in the body is too low, it can easily lead to bleeding of the skin mucous membranes and organs. If the condition is not effectively controlled, deterioration is possible, such as a progressive decline in platelet index. If the patient is asymptomatic or the symptoms are relatively mild, treatment is usually not required, and only regular rechecking of platelet levels is sufficient. Specific therapeutic drugs include prednisone and gammaglobulin. Patients with primary immune thrombocytopenia should consult the hematology department and take appropriate treatment measures under the guidance of the doctor.